Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PRRT with Lu-177 DOTATATE in Treatment-Refractory Progressive Meningioma: Initial Experience from a Tertiary-Care Neuro-Oncology Center.
Puranik AD, Dev ID, Rangarajan V, Kulkarni S, Shetty N, Gala K, Sahu A, Bhattacharya K, Dasgupta A, Chatterjee A, Gupta T, Sridhar E, Sahay A, Shetty P, Singh V, Moiyadi A, Menon N, Purandare NC, Agrawal A, Shah S, Choudhury S, Ghosh S, Jha AK. Puranik AD, et al. Among authors: purandare nc. Neurol India. 2024 Mar 1;72(2):278-284. doi: 10.4103/NI.Neurol-India-D-23-00252. Epub 2024 Apr 30. Neurol India. 2024. PMID: 38691470 Free article.
Can 18F FDG PET/CT metabolic parameters be used to noninvasively differentiate between different histopathological subtypes and Fuhrman grades of renal cell cancer?
Jain Y, Agrawal A, Joshi A, Menon S, Prakash G, Murthy V, Purandare N, Shah S, Puranik A, Choudhury S, Shukla V, Dev I, Prabhash K, Noronha V, Rangarajan V. Jain Y, et al. Among authors: purandare n. Nucl Med Commun. 2024 Apr 30. doi: 10.1097/MNM.0000000000001844. Online ahead of print. Nucl Med Commun. 2024. PMID: 38686492
Clinical outcomes of ROS1-positive non-small cell lung cancer with limited access to ROS1-tyrosine kinase inhibitors (TKIs): experience from an Indian tertiary referral centre.
Panda GS, Noronha V, Patil V, Joshi A, Menon N, Kumar R, Pai T, Shetty O, Janu A, Chakrabarty N, Purandare N, Dey S, Prabhash K. Panda GS, et al. Among authors: purandare n. Ecancermedicalscience. 2024 Jan 15;18:1654. doi: 10.3332/ecancer.2024.1654. eCollection 2024. Ecancermedicalscience. 2024. PMID: 38425761 Free PMC article.
Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer.
Puranik AD, Choudhury S, Ghosh S, Dev ID, Ramchandani V, Uppal A, Bhosale V, Palsapure A, Rungta R, Pandey R, Khatri S, George G, Satamwar Y, Maske R, Agrawal A, Shah S, Purandare NC, Rangarajan V. Puranik AD, et al. Among authors: purandare nc. Indian J Cancer. 2024 Jan 1;61(Suppl 1):S1-S28. doi: 10.4103/ijc.ijc_52_24. Epub 2024 Mar 1. Indian J Cancer. 2024. PMID: 38424680 Free article.
A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC.
Noronha V, Menon NS, Patil VM, Chandrakanth MV, More S, Dhanawat A, Chowdhary OR, Singh AC, Goud S, Shah S, Karuvandan N, Jobanputra KN, Shah DK, Shah MJ, Sarma R, Patel D, Joarder R, Kumar P, John A, Kaur J, Bagra S, Purandare N, Janu A, Mahajan A, Prabhash K. Noronha V, et al. Among authors: purandare n. JTO Clin Res Rep. 2023 Dec 18;5(1):100622. doi: 10.1016/j.jtocrr.2023.100622. eCollection 2024 Jan. JTO Clin Res Rep. 2023. PMID: 38292414 Free PMC article.
The Role of Systemic Therapy in Patients with Advanced Non-small Cell Lung Cancer and a Poor Eastern Cooperative Oncology Group Performance Status.
Shah M, Noronha V, Patil V, Menon N, Singh AK, Shah A, Kumar P, Roychoudhary O, Peelay Z, Janu A, Purandare N, Chakrabarty N, Patil V, Kaushal R, Shetty O, Pai T, Chandrani P, Chougule A, Prabhash K. Shah M, et al. Among authors: purandare n. Clin Oncol (R Coll Radiol). 2024 Feb;36(2):128-129. doi: 10.1016/j.clon.2023.12.001. Epub 2023 Dec 10. Clin Oncol (R Coll Radiol). 2024. PMID: 38097463 No abstract available.
Post-Renal Transplant Lymphoproliferative Disorder.
Jain Y, Purandare N, Agrawal A, Shah S, Puranik A, Rangarajan V. Jain Y, et al. Among authors: purandare n. Radiol Imaging Cancer. 2024 Jan;6(1):e230075. doi: 10.1148/rycan.230075. Radiol Imaging Cancer. 2024. PMID: 38063506 Free PMC article. No abstract available.
FIGO statement: Fertility preservation.
Henry L, Berek JS, Diaz I, Feldberg D, Mocanu E, Niederberger CC, Ohlander S, Purandare N, Rosenwaks Z, Tulandi T, Wasson M, Wilailak S, Malhotra J. Henry L, et al. Among authors: purandare n. Int J Gynaecol Obstet. 2023 Dec;163(3):790-794. doi: 10.1002/ijgo.15187. Epub 2023 Oct 9. Int J Gynaecol Obstet. 2023. PMID: 37807831 Free article.
431 results